The impact of atrial prevention and termination therapies on atrial tachyarrhythmia burden in patients receiving a dual-chamber defibrillator for ventricular arrhythmias. [electronic resource]
Producer: 20040817Description: 103-10 p. digitalISSN:- 1383-875X
- Aged
- Anti-Arrhythmia Agents -- therapeutic use
- Atrial Fibrillation -- etiology
- Atrial Flutter -- etiology
- Cardiac Pacing, Artificial
- Chi-Square Distribution
- Defibrillators, Implantable -- adverse effects
- Electrocardiography
- Female
- Follow-Up Studies
- Humans
- Incidence
- Male
- Middle Aged
- Probability
- Prospective Studies
- Risk Assessment
- Severity of Illness Index
- Survival Rate
- Tachycardia, Ventricular -- diagnosis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.